About The Cooper Companies, Inc. - Common Stock (COO)
Cooper Companies is a global medical device company that specializes in the design, manufacture, and marketing of innovative products in the eye care and women's health sectors. The company is best known for its extensive range of contact lenses, which cater to various needs including vision correction and lifestyle enhancements. Additionally, Cooper Companies offers a suite of women’s health products, particularly in the areas of fertility and other reproductive health solutions, aiming to improve the quality of life for individuals worldwide. Through its commitment to research and development, the company seeks to advance technology and provide high-quality, effective solutions for its customers. Read More
Cooper Companies (NASDAQ:COO) reported record revenue and non-GAAP earnings for its fiscal second quarter of 2026, while management said it is advancing discussions with multiple parties interested in CooperSurgical as part of its strategic review.
President and Chief Executive Officer Albert White
Medical device company CooperCompanies (NASDAQ:COO) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 7.9% year on year t...
SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2026.
Medical device company CooperCompanies (NASDAQ:COO) will be reporting earnings this Thursday after the bell. Here’s what investors should know. CooperCompani...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloade...
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...
SAN RAMON, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Paul Keel as an independent director, effective July 1, 2026. Mr. Keel has also been appointed to serve on the Audit Committee when he joins the Board.
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
SAN RAMON, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report second quarter 2026 financial results on Thursday, June 4, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...
MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, effective May 11, 20261, as part of Board expansion and succession planning:
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
CooperCompanies’ fourth quarter was met with a negative market reaction, as investors focused on the company’s slower organic revenue growth and ongoing chal...
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Medical device company CooperCompanies (NASDAQ:COO) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.2% year on year to $1.02 billion. Th...
Medical device company CooperCompanies (NASDAQ:COO) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 6.2% year on year to $1.02 billion. Th...
